When can you learn? Everyone working on DC vaccine for cancer would love to have DCs load tumor-associated antigens as many as possible. Why cannot you grasp such as simple idea? It is intuitive the more target information is provided for immune system, the better the efficacy is.
The reason all those DC vaccines failed to make breakthrough in treating cancer is that they cannot load enough tumor-associated antigens.
Dr. Lisa Butterfield and Dr. Pawel Kalinski wrote a bunch of papers. Do you think Dr. Lisa Butterfield should know very well about DCVax-L?
You should know I was the one who first mentioned about BCG. Your talking point is boring. If you talk about the possible replacement, I might have interest.